ArticleInvestigational new drugs2020

Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.

Masashi Ishikawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.